Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Inventory (2021 - 2023)

Historic Change in Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Q4 2023 value amounting to -$167000.0.

  • ADC Therapeutics' Change in Inventory fell 10172.93% to -$167000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year decrease of 4081.44%. This contributed to the annual value of $3.7 million for FY2024, which is 3473.39% down from last year.
  • ADC Therapeutics' Change in Inventory amounted to -$167000.0 in Q4 2023, which was down 10172.93% from $3.5 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Inventory ranged from a high of $9.7 million in Q4 2022 and a low of -$167000.0 during Q4 2023
  • For the 3-year period, ADC Therapeutics' Change in Inventory averaged around $1.5 million, with its median value being -$174.0 (2021).
  • Within the past 5 years, the most significant YoY rise in ADC Therapeutics' Change in Inventory was 46821173.05% (2022), while the steepest drop was 2671428.57% (2022).
  • Quarter analysis of 3 years shows ADC Therapeutics' Change in Inventory stood at -$2063.0 in 2021, then soared by 468211.73% to $9.7 million in 2022, then tumbled by 101.73% to -$167000.0 in 2023.
  • Its last three reported values are -$167000.0 in Q4 2023, $3.5 million for Q3 2023, and $2.1 million during Q2 2023.